NEWS
Enhancement and expansion for CDCs
The Government has announced further investment and expansion of Community Diagnostic Centres (CDCs), with £237 million funding for four new centres and significant enhancements to 32 more. The new investment is part of the
extra £26 billion a year for the NHS and will significantly boost NHS diagnostic capacity and deliver more care in local communities. The NHS in England carried out a record 29 million diagnostic tests in 2025 thanks to Government modernisation and investment. Professor Stella Vig, National Clinical
Director for Elective Care at NHS England, said: “We’re making it easier to access care, and our network of Community Diagnostic Centres deliver important diagnostic tests nearer to people’s homes, with new, expanded or enhanced centres available to patients across England. This expansion means even more patients can have vital checks in a convenient location at a time that suits them, supporting the NHS’s drive to bring down waiting times even further. Four new CDCs, all equipped with state-
of-the-art facilities, will open in Gorton, Luton, Boston and Bideford during 2026/27. A further 32 centres will be expanded
and improved with new scanning equipment, outpatient clinic space and additional testing facilities. Of these, 17 will be physically expanded with new rooms and state-of-the-art scanning and diagnostic equipment - such as MRI, CT and ultrasound scanners - significantly increasing the range and volume of tests each centre can offer. A further 15 will receive targeted enhancements, adding specialist kit, new clinic rooms or additional services such as audiology, ophthalmology and respiratory care to existing facilities. A full list of the CDCs due for expansion and enhancement can be found below. There are currently 170 CDCs in
operation across England, with 108 currently open 12 hours a day, seven days a week.
OBN rebrands to BioUK
OBN (UK) the not-for-profit membership organisation focused on catalysing success UK life sciences, has announced that it is changing its name to BioUK. This updated brand identity has been
developed to align with the organisation’s position following a period of sustained growth – providing support throughout the UK to help R&D SMEs to create connections, save time and money and secure investment through a portfolio of tailored events and services. Initially founded in 1996, the
Oxfordshire Bioscience Network was rebranded as OBN (UK) Ltd in 2008, recognising its growing network of members outside of the Oxfordshire region. Since then, it has continued to expand, now comprising of around 540 member companies from across the UK
life-science sector (with close to 60% being R&D SMEs), supporting growth through access to an extensive support ecosystem of investors, pharma,
science parks and professional service companies. As well as offering forums to atract
investment, BioUK provides specialist support for early-stage SMEs, where resources and budget are often limited. BioUK launched its coaching programme last year – a portfolio of specialist 1:1 and group coaching options that connect founders with experienced industry coaches, providing access to the knowledge and expertise needed to navigate investor expectations, strengthen strategic decision- making and scale successfully. To find out more about BioUK and its
mission to catalyse success in life sciences, please visit
www.biouk.com/
May 2026
WWW.PATHOLOGYINPRACTICE.COM 11
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52
